NDA
Bejelentkezés
Kapcsolat
Angiotensin type 1A receptor regulates β-arrestin binding of the β2-adrenergic receptor via heterodimerization |
Tartalom: | http://real.mtak.hu/49000/ |
---|---|
Archívum: | MTA Könyvtár |
Gyûjtemény: |
Status = Published
Type = Article |
Cím: |
Angiotensin type 1A receptor regulates β-arrestin binding of the β2-adrenergic receptor via heterodimerization
|
Létrehozó: |
D. Tóth, András
Gyombolai, Pál
Szalai, Bence
Várnai, Péter
Turu, Gábor
Hunyady, László
|
Kiadó: |
Elsevier
|
Dátum: |
2017
|
Téma: |
QH3015 Molecular biology / molekuláris biológia
RC Internal medicine / belgyógyászat
|
Tartalmi leírás: |
Heterodimerization between angiotensin type 1A receptor (AT1R) and β2-adrenergic receptor (β2AR) has been shown to modulate G protein-mediated effects of these receptors. Activation of G protein-coupled receptors (GPCRs) leads to β-arrestin binding, desensitization, internalization and G protein-independent signaling of GPCRs. Our aim was to study the effect of heterodimerization on β-arrestin coupling. We found that β-arrestin binding of β2AR is affected by activation of AT1Rs. Costimulation with angiotensin II and isoproterenol markedly enhanced the interaction between β2AR and β-arrestins, by prolonging the lifespan of β2AR-induced β-arrestin2 clusters at the plasma membrane. While candesartan, a conventional AT1R antagonist, had no effect on the β-arrestin2 binding to β2AR, TRV120023, a β-arrestin biased agonist, enhanced the interaction. These findings reveal a new crosstalk mechanism between AT1R and β2AR, and suggest that enhanced β-arrestin2 binding to β2AR can contribute to the pharmacological effects of biased AT1R agonists. © 2016
|
Nyelv: |
angol
|
Típus: |
Article
PeerReviewed
info:eu-repo/semantics/article
|
Formátum: |
text
|
Azonosító: |
D. Tóth, András and Gyombolai, Pál and Szalai, Bence and Várnai, Péter and Turu, Gábor and Hunyady, László (2017) Angiotensin type 1A receptor regulates β-arrestin binding of the β2-adrenergic receptor via heterodimerization. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 442. pp. 113-124. ISSN 0303-7207
|
Kapcsolat: |
MTMT:3171969; doi:10.1016/j.mce.2016.11.027
|